Don't know.
From what's been said publicly they would prefer to sell products into the non-hospital, clinical podiatry space using an established sales force rather than developing their own.
They must think that realistic opportunities might become available -- it's not pie-in-the-sky, wishful thinking. It strikes me that DW is not a fantasist and is comfortable with thinking along such lines as he has deep M&A experience.
Don't know. From what's been said publicly they would prefer to...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.29 |
Change
0.000(0.00%) |
Mkt cap ! $1.580B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 698 | $2.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.11 | 5162 | 1 |
View Market Depth
| Last trade - 09.45am 09/05/2024 (20 minute delay) ? |
| PNV (ASX) Chart |
Day chart unavailable